BUSINESS BRIEF
A medical technology company focused on developing novel yet affordable medical devices that enable high-quality surgical and urological care, particularly for emerging markets. The company operates across surgical endo-vision systems, AI-enabled surgical platforms, and patented urology consumables, supported by strong in-house R&D and manufacturing capabilities.
Key Highlights:
- Affordable alternatives to premium global surgical systems
- AI-enabled surgical collaboration and learning platform
- Strong IP protection with 20+ patents applied and 4 granted
- Serves emerging markets with highest quality, costeffective, OR-ready solutions
- Regulatory Status: US FDA Cleared, CDSCO (India) Approved, CE Certification – In Progress
- Core Scientific Strength in AI, surgical vision, optics, materials, fluorescence oncology marker , fluid & gas management
- Global-Standard Products with advanced endo-vision & SaaS
- Defensible IP with strong patent portfolio & in-house R&D
Business Divisions
- Surgical Endo-Vision & OR Equipment
- Surgical AI & SaaS Platforms (CogniAxis / ASAS)
- Urology Devices & Fluid Management
- Innovation Capture Platform (SUFI)
Products & Services
- Surgical Endo-Vision & Operating Room Equipment
- AI-based Surgical Assistance & SaaS Platform
- Patented Urology Fluid Management & Smart Consumables
- Innovation capture and clinician co-creation platform
Proposal
Industry
Hospitals and Healthcare
Sub Industry
Medical Equipment and Devices
Nature of Business
B2B
Sector
Manufacturing (Own Brand)
Region
South-east Asia
Open For Dilution
10 %
Top Customer
Ask
INR 130 Cr
End use of fund
- Research & Development
- Regulatory approvals and licenses
- Marketing and market expansion
- Working capital
- Machinery and manufacturing upgrades
Business Operation Information
Financial Information |
2025 (in INR Cr) | 2024 (in INR Cr) | 2023 (in INR Cr) |
|---|---|---|---|
Sales |
24.18 | 8.92 | 4.35 |
EBITDA |
|||
PAT |
